NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
4.730
+0.110 (2.38%)
At close: Dec 20, 2024, 4:00 PM
4.896
+0.166 (3.50%)
After-hours: Dec 20, 2024, 7:18 PM EST
NEXGEL Employees
NEXGEL had 19 employees as of December 31, 2023. The number of employees increased by 7 or 58.33% compared to the previous year.
Employees
19
Change (1Y)
7
Growth (1Y)
58.33%
Revenue / Employee
$354,158
Profits / Employee
-$185,737
Market Cap
35.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAB Biotherapeutics | 57 |
| Actinium Pharmaceuticals | 49 |
| Movano | 30 |
| Outlook Therapeutics | 24 |
| Lantern Pharma | 21 |
| OneMedNet | 20 |
| VYNE Therapeutics | 10 |
| Nexalin Technology | 6 |
NXGL News
- 5 weeks ago - NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially - GlobeNewsWire
- 5 weeks ago - NEXGEL Announces $2,000,000 Registered Direct Offering - GlobeNewsWire
- 2 months ago - NEXGEL to Participate in Upcoming October Investor Conferences - GlobeNewsWire
- 2 months ago - NEXGEL Appoints Kip Crecca to its Scientific Advisory Board - GlobeNewsWire
- 4 months ago - NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million - GlobeNewsWire
- 4 months ago - NEXGEL to Report Second Quarter 2024 Financial Results on August 14th - GlobeNewsWire